Inhibition of BRCA2 and Thymidylate Synthase Creates Multidrug Sensitive Tumor Cells via the Induction of Combined “Complementary Lethality”

A high mutation rate leading to tumor cell heterogeneity is a driver of malignancy in human cancers. Paradoxically, however, genomic instability can also render tumors vulnerable to therapeutic attack. Thus, targeting DNA repair may induce an intolerable level of DNA damage in tumor cells. BRCA2 med...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rytelewski, Mateusz, Ferguson, Peter J, Vareki, Saman Maleki, Figueredo, Rene, Vincent, Mark, Koropatnick, James
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3615817/
https://ncbi.nlm.nih.gov/pubmed/23481354
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtna.2013.7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados